Statins: another class of antihypertensive agents?

Journal of Human Hypertension
H J MilionisDimitri P Mikhailidis

Abstract

The assessment of global cardiovascular risk is an essential step in the management of atherosclerotic disease prevention. Among the risk factors to be addressed are hypertension and hyperlipidaemia; these commonly coexist. A neutral or lipid-friendly antihypertensive agent is probably useful in the presence of lipid abnormalities. Similarly, statins have been shown to decrease cardiovascular risk in hypertensive patients. There is also experimental and clinical evidence that statins have blood pressure (BP)-lowering effects. In this review, we discuss the beneficial effects of statins on BP, and provide an overview of the underlying pathophysiology. We also consider the evidence justifying the use of statins in the management of hypertensive patients.

References

Mar 1, 1990·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·T MorganG Macaskill
Mar 1, 1990·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·M LaurenziA Zanchetti
May 1, 1990·Scandinavian Journal of Clinical and Laboratory Investigation·J BülowL Højgaard
Jun 1, 1995·The American Journal of Physiology·R H Cox, T N Tulenko
Jan 1, 1995·European Journal of Clinical Pharmacology·M KoolL Van Bortel
Feb 11, 1995·Lancet·G K GoodeA M Heagerty
Jan 1, 1993·The American Journal of Cardiology·R B D'AgostinoL C D'Agostino
Feb 7, 1998·Hypertension·T W WilsonR J Roman
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·M EndresJ K Liao
Dec 5, 1998·International Journal of Epidemiology·A Fagot-CampagnaE Eschwège
Dec 5, 1998·The New England Journal of Medicine·UNKNOWN Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
Jun 5, 1999·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·A GottsäterF Lindgärde
Dec 15, 2000·European Journal of Clinical Investigation·G TonoloM Maioli

❮ Previous
Next ❯

Citations

Aug 19, 2007·Heart Failure Reviews·Sofia G TsouliMoses S Elisaf
Oct 11, 2008·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Chengyun LiuXuelin Chen
Jun 1, 2010·Current Atherosclerosis Reports·Joshua Liao, John A Farmer
May 24, 2007·Current Hypertension Reports·Haralampos J MilionisDimitri P Mikhailidis
Aug 20, 2009·Cardiology in Review·Emmanuel S AndroulakisChristodoulos Stefanadis
Dec 22, 2010·Lipids in Health and Disease·Krishnaswami Vijayaraghavan
Jan 23, 2009·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Ilke Sipahi, E Murat Tuzcu
May 26, 2010·Expert Opinion on Pharmacotherapy·Michael S KostapanosMoses S Elisaf
Apr 22, 2008·Expert Opinion on Pharmacotherapy·C V RizosM S Elisaf
Feb 18, 2011·Expert Opinion on Emerging Drugs·Matilda FlorentinMoses S Elisaf
Dec 4, 2008·Scandinavian Journal of Clinical and Laboratory Investigation·L PaulsenE B Pedersen
Jun 27, 2009·Current Medical Research and Opinion·Mariusz StepienJacek Rysz
May 23, 2012·Pharmacology & Therapeutics·Dimitris TousoulisChristodoulos Stefanadis
Nov 11, 2006·Atherosclerosis·D N KiortsisE N Liberopoulos
Aug 19, 2007·European Journal of Clinical Investigation·F Simko
Nov 28, 2013·Clinical Science·Philip J Millar, John S Floras
Aug 1, 2007·Journal of Vascular Surgery·Kosmas I ParaskevasDimitri P Mikhailidis
Feb 7, 2012·International Journal of Cardiology·Anna GlubaMaciej Banach
Jan 19, 2008·American Journal of Hypertension·Maria S KosmidouHaralampos J Milionis
Nov 16, 2007·Pharmacoepidemiology and Drug Safety·Gholamreza SepehriMottahareh Mohsenbeigi
Mar 1, 2018·Pharmaceutical Biology·Emily Guzman, Jeanmaire Molina
Jul 28, 2011·American Journal of Nephrology·Rigas G Kalaitzidis, Moses S Elisaf

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Current Hypertension Reports
Haralampos J MilionisDimitri P Mikhailidis
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Panagiotis KorantzopoulosHaralampos J Milionis
Trends in Pharmacological Sciences
Chiara MarchesiErnesto L Schiffrin
© 2021 Meta ULC. All rights reserved